Efficacy and safety of didpeptidyl peptidase 4 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis of 116 trials

24 May 2016 (10:24 - 10:30)
Organised by:
Congress Presentation Part of: Moderated Poster Session 6 - Comorbidities Metabolism / Diabetes mellitus HFA Premium Access HEART FAILURE 2016

ESC 365 is supported by

ESC 365 is supported by